Published in Eur J Clin Microbiol on June 01, 1984
Vaccinations for adult solid-organ transplant recipients: current recommendations and protocols. Clin Microbiol Rev (2003) 1.28
Soluble mediators of inflammation in HIV and their implications for therapeutics and vaccine development. Cytokine Growth Factor Rev (2012) 0.94
Nature of immunological non-responsiveness to hepatitis B vaccine in healthy individuals. Immunology (1988) 0.88
Interleukin 1 activity in the synovial fluid of patients with rheumatoid arthritis. Rheumatol Int (1982) 2.24
Normothermia versus hypothermia during cardiopulmonary bypass: a randomized, controlled trial. Ann Thorac Surg (1995) 1.89
Frequent chronic hepatitis B virus infection in HIV-infected patients positive for antibody to hepatitis B core antigen only. Swiss HIV Cohort Study. Eur J Clin Microbiol Infect Dis (1998) 1.69
Faecal S.H. (Australia) antigen in acute hepatitis. Lancet (1971) 1.60
Cluster of hepatitis B transmitted by a physician. Lancet (1981) 1.57
Retroperitoneal fibrosis. Response to corticosteroid therapy. Arch Intern Med (1971) 1.56
Simple monitoring of antiretroviral therapy with a signal-amplification-boosted HIV-1 p24 antigen assay with heat-denatured plasma. AIDS (1997) 1.50
Acute parathyroid hormone response to epinephrine in vivo. J Clin Invest (1973) 1.49
Nature and rate of vascular refilling during hemodialysis and ultrafiltration. Kidney Int (1992) 1.46
Hepatitis B vaccination of high-risk individuals in the canton of Zurich. Eur J Clin Microbiol (1983) 1.43
Impact of time-interval after transplantation and therapy with fibrates on serum cholesterol levels in renal transplant patients. Clin Nephrol (1993) 1.39
[Factors determining the choice of a modality of treatment by dialysis: a study of nine dialysis centers]. Nephrologie (2000) 1.39
Recurrence of Fabry's disease in a renal allograft 14 years after transplantation. Nephrol Dial Transplant (1995) 1.38
Pharmacokinetics of the antibacterial combination sulfamethoxazole plus trimethoprim in patients with normal or impaired kidney function. Antibiot Chemother (1971) (1974) 1.37
HIV-associated primary pulmonary hypertension. A case control study. Swiss HIV Cohort Study. Am J Respir Crit Care Med (1997) 1.35
Neuropsychiatric side effects of mefloquine. N Engl J Med (1990) 1.21
Pancreatitis after renal transplantation. Gut (1975) 1.21
Human parathyroid hormone. Immunological characterization of antibodies against a glandular extract and the synthetic amino-terminal fragments 1-12 and 1-34 and their use in the determination of immunoreactive hormone in human sera. J Clin Invest (1974) 1.20
Pharmacokinetic studies on the oral antimycotic agent 5-fluorocytosine in individuals with normal and impaired kidney function. Chemotherapy (1973) 1.19
Borderline low thyroid function and thyroid autoimmunity. Risk factors for coronary heart disease? Br Heart J (1981) 1.18
Prospective evaluation of pretransplant blood transfusions in cadaver kidney recipients. Transplantation (1997) 1.15
Interaction of IgG and its fragments with red cells. Immunology (1967) 1.15
Highly active antiretroviral therapy during early HIV infection reverses T-cell activation and maturation abnormalities. Swiss HIV Cohort Study. AIDS (1998) 1.12
[To which travelers abroad should immunization against hepatitis be recommended?]. Soz Praventivmed (1982) 1.12
Intranasal interferon (rIFN-alpha A, Ro 22-8181) for contact prophylaxis against common cold: a randomized, double-blind and placebo-controlled field study. Antiviral Res (1986) 1.10
Metabolic studies with 5-fluorocytosine-6-14C in mouse, rat, rabbit, dog and man. Chemotherapy (1976) 1.08
Multiple myeloma and HHV8 infection. Blood (1998) 1.08
[How great is the risk of hepatitis due to travel? Retrospective study in the region of Zurich 1971-1976]. Schweiz Med Wochenschr (1977) 1.08
Experimental production in rabbits of antiepithelial autoantibodies. J Invest Dermatol (1967) 1.07
Oxidative injury to erythrocytes, cell rigidity, and splenic hemolysis in hemodialyzed uremic patients. Ann Intern Med (1975) 1.05
Studies on the mechanism of immunoglobulin binding to red cells. Immunology (1967) 1.05
Immunological abnormalities and hydantoins. Br Med J (1972) 1.04
IgA deficiency, epilepsy, and hydantoin medication. Lancet (1976) 1.03
Detection of HBs antigen in "anti-HBc alone" positive sera. J Hepatol (1994) 1.02
Drug-induced pseudolupus. Lancet (1975) 1.01
Stomatococcus mucilaginosus as an agent of CAPD peritonitis. Zentralbl Bakteriol Mikrobiol Hyg A (1988) 1.01
[Tumor markers and immunomodulator substances in ascites--their value as screening and diagnosis parameters]. Schweiz Med Wochenschr (1989) 1.01
Effect of human exogenous leukocyte interferon in cytomegalovirus infections. J Infect Dis (1976) 0.99
Destruction of epithelial cells in vivo by antiepithelial autoantibodies. J Invest Dermatol (1967) 0.98
[Hepatitis serological finding "anti-HBc alone", circulating viral DNA and interpretation of findings]. Schweiz Med Wochenschr (1993) 0.97
Seroprevalence of hepatitis and HIV infection among rural pregnant women in Cameroon. APMIS (1994) 0.96
Reports on cephtriaxone (Rocephin). Introduction and review. Chemotherapy (1981) 0.96
Prevalence and significance of anti-HBc IgM (radioimmunoassay) in acute and chronic hepatitis B and in blood donors. Hepatology (1983) 0.95
Control of epidemic meningococcal meningitis by mass vaccination. Lancet (1981) 0.95
Effects of work demands on immunoglobulin A and cortisol in air traffic controllers. Biol Psychol (1996) 0.95
A blood protein monitor for the continuous measurement of blood volume changes during hemodialysis. Kidney Int (1990) 0.94
Circulating immune complexes, complement factors C3, C4, C1-inhibitor, alpha-1-antitrypsin and immunoglobulins in asthmatic patients. Respiration (1981) 0.94
Pharmacokinetics and dosage adjustment of cefotiam in renal impaired patients. J Antimicrob Chemother (1984) 0.94
Renal pathology and premortem clinical presentation of Caucasian patients with AIDS: an autopsy study from the era prior to antiretroviral therapy. Swiss Med Wkly (2001) 0.93
Prevalence of markers of hepatitis viruses A, B, C and of HIV in healthy individuals and patients of a Cambodian province. Southeast Asian J Trop Med Public Health (1993) 0.93
Polyvalent immunoglobulins for prophylaxis of bacterial infections in patients following multiple trauma. A randomized, placebo-controlled study. Intensive Care Med (1985) 0.93
Percutaneous transluminal dilatation for restoration of angioaccess in chronic hemodialysis patients. Cardiovasc Intervent Radiol (1982) 0.93
Heroin associated nephropathy: clinical and histological studies in 19 patients. Clin Nephrol (1979) 0.91
A long-term functioning human pancreatic islet allotransplant. Transplantation (1980) 0.90
Antibodies against Australiantigen in laboratory personnel. Lancet (1971) 0.90
[Hepatitis epidemiology in Switzerland]. Schweiz Med Wochenschr (1973) 0.89
Relation of cyclosporine blood levels to adverse effects on lipoproteins. Transplantation (1994) 0.89
[Hepatitis and HIV infection in users of illegal drugs]. Schweiz Med Wochenschr (1992) 0.88
The interpretation of abnormal sexchromatin incidence in human breast tumors on the basis of DNA measurements. Eur J Cancer (1968) 0.88
Cytokine production and visualized effects in the feto-maternal unit. Quantitative and topographic data on cytokines during intrauterine disease. Lab Invest (1995) 0.87
[Incidence of HBsAG in symptom-free pregnant women. Results of screening at the University of Zurich Gynecology Clinic]. Schweiz Med Wochenschr (1984) 0.87
Stimulation of Na+/H+ exchange activity by endothelin in opossum kidney cells. Pflugers Arch (1995) 0.86
Serum S100--a marker for disease monitoring in metastatic melanoma. Dermatology (1997) 0.86
Differential effect of impaired renal function on the kinetics of clavulanic acid and amoxicillin. Antimicrob Agents Chemother (1986) 0.85
Metabolic aspects of phosphate replacement therapy for hypophosphatemia after renal transplantation: impact on muscular phosphate content, mineral metabolism, and acid/base homeostasis. Am J Kidney Dis (1999) 0.85
Therapeutic uses of transfer factor. Prog Clin Immunol (1974) 0.85
Peritonitis during continuous ambulatory peritoneal dialysis: improving patient defense by type of buffer of dialysate? Nephron (1981) 0.85
Parathyroid hormone responses to catecholamines and to changes of extracellular calcium in cows. J Clin Invest (1978) 0.85
Altered intracellular expression of the chemokines MIP-1alpha, MIP-1beta and IL-8 by peripheral blood CD4+ and CD8+ T cells in mild allergic asthma. Allergy (2003) 0.85
A randomized controlled clinical trial of topical photodynamic therapy with methyl aminolaevulinate in the treatment of actinic keratoses in transplant recipients. Br J Dermatol (2004) 0.85
[Calcium ion concentration in the serum. Findings in two age groups in both sexes; relation to the total calcium and the ultrafiltered calcium; results in dysfunction of the parathyroid glands]. Schweiz Med Wochenschr (1972) 0.85
1,25-dihydroxyvitamin D3 stimulates transforming growth factor-beta1 synthesis by mouse renal proximal tubular cells. Kidney Blood Press Res (1999) 0.84
[Relationship between sex chromatin incidence, nuclear size and DNA content in breast tumors and its significance for the survuval rate]. Schweiz Med Wochenschr (1967) 0.84
The acute parathyroid hormone response to changes in ionized calcium during phosphate infusions in the cow. Eur J Clin Invest (1973) 0.84
Immunological alterations in the ejaculate of chronic prostatitis patients: clues for autoimmunity. Andrologia (2003) 0.84
Anti-HIV IgM antibody analysis during early manifestations of HIV infections. AIDS (1987) 0.84
Effects of glucocorticoid deficiency on renal medullary cyclic adenosine monophosphate of rats. Clin Sci Mol Med (1978) 0.84
Levels of soluble interleukin-2 receptors correlate with the severity of atopic dermatitis. Dermatologica (1990) 0.83
[Strongyloidiasis following kidney transplantation]. Schweiz Med Wochenschr (1978) 0.83
Effect of a herbal yeast food supplement and long-distance running on immunological parameters. Br J Sports Med (1990) 0.83
Differential use of cardiac troponin T versus I in hemodialysis patients. Clin Nephrol (2003) 0.83
Human urinary fluoride excretion as influenced by renal functional impairment. Nephron (1980) 0.83
Nonspecific immune parameters and hepatitis B antigens in patients with uveitis. Mod Probl Ophthalmol (1976) 0.83
Fecal SH-antigen in acute hepatitis. Am J Dis Child (1972) 0.83
Improved detection of antibodies to hepatitis C virus by use of a new recombinant immunoblot assay. Eur J Clin Microbiol Infect Dis (1993) 0.82
Clinical experience with 1000 patients treated with cefetamet pivoxil. Curr Med Res Opin (1989) 0.82
BA and SH antigen in chronic hepatitis. Gastroenterology (1971) 0.82
Influence of 1,25 dihydroxycholecalciferol on sexual dysfunction and related endocrine parameters in patiens on maintenance hemodialysis. Clin Nephrol (1980) 0.82
Astrocyte-derived interleukin-1-like factors. Lymphokine Res (1984) 0.82
Prevalence of hepatitis A antibodies in Swiss travellers. Eur J Epidemiol (1993) 0.81
Immunogenicity of a hepatitis B subunit vaccine in hemodialysis and in renal transplant recipients. Antiviral Res (1983) 0.81